The Netherlands
-
Europe's latest group of large IPOs are gaining traction with investors but bankers fear another Deliveroo -
US food and drink company monetizes portion of its stake in JDE Peet without selling
-
The €880m share sale by Credit Suisse, BNP Paribas and Hellman & Friedman was multiple times covered, according to sources
-
Call centre operator Marjorel is the latest international company to have chosen Amsterdam as a listing venue
-
A €100m convertible bond will finance CM.com's growth — both financial and physical, according to its co-founder and CEO Jeroen van Glabbeek
-
Tony Hayward, the former boss of BP, is joining this year’s $117bn Spac IPO market by launching a new blank cheque company on the Amsterdam Stock Exchange that will focus on energy transition.
-
Bulgarian animal healthcare company Huvepharma has become the latest casualty in an IPO market oversaturated with supply.
-
Animal healthcare company Huvepharma has opened the books on its €463m IPO on the Amsterdam Stock Exchange.
-
A new special purpose acquisition company focused on the decarbonisation industry has launched an IPO on the Amsterdam Stock Exchange, with the backing of cornerstone investors.
-
Trading levels given are bid-side spreads versus mid-swaps and/or an underlying benchmark and bid-yields from the close of business on Monday, June 14. The source for secondary trading levels is ICE Data Services.
-
Two European animal healthcare companies have announced their intention to float in recent days. Bankers hope that the fast growing sector will offer something different in a crowded pipeline of new stockmarket listings in the region.
-
